Given that colorectal cancer patients exhibit infrequent IFN- and MHC-signaling gene mutations and are generally resistant to ICB, a recent study has explored alternative mechanisms that may constrain IFNγ signaling in colorectal cancer [69]. Here, IFNA1 is linked to colorectal cancer.